Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Angion Biomedica Corp. (merged with Elicio Therapeutics, privately-held) (ANGN)

  • SEC News
  • Dec. 10, 2025, 22:05 UTC
  • 0
  • 1 comments

DeMuth Peter 🟡 adjusted position in 0 shares (1 derivative) of Elicio Therapeutics, Inc. (ELTX) at $4.41 Transaction Date: Dec 09, 2025 | Filing ID: 000130

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:05 UTC
  • 0
  • 1 comments

📋 MPM Asset Management LLC (Shareholder) plans to sell 14K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $14K) Filed: Dec 10, 2025 | ID: 056353

Comment Full text

Structure Therapeutics Inc (GPCR)

  • SEC News
  • Dec. 10, 2025, 22:04 UTC
  • 0
  • 0 comments

New Form 424B5 - Structure Therapeutics Inc. Filed: 2025-12-10 AccNo: 0001104659-25-120013 Size: 1 MB

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:04 UTC
  • 0
  • 1 comments

📋 MPM Oncology Innovations Fund, L.P. (Shareholder) plans to sell 20K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $20K) Filed: Dec 10, 2025 | ID: 056352

Comment Full text

Jazz Pharmaceuticals plc (JAZZ)

  • SEC News
  • Dec. 10, 2025, 22:03 UTC
  • 0
  • 0 comments

New Form 3 - Jazz Pharmaceuticals plc Filed: 2025-12-10 AccNo: 0001188919-25-000006 Size: 3 KB

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:03 UTC
  • 0
  • 1 comments

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 73K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $74K) Filed: Dec 10, 2025 | ID: 056351

Comment Full text

Coeptis Therapeutics Holdings Inc (COEP)

  • SEC News
  • Dec. 10, 2025, 22:03 UTC
  • 0
  • 0 comments

New Form S-4/A - Coeptis Therapeutics Holdings, Inc. Filed: 2025-12-10 AccNo: 0001683168-25-009045 Size: 15 MB

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:02 UTC
  • 0
  • 1 comments

📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 3K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $3K) Filed: Dec 10, 2025 | ID: 056349

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:02 UTC
  • 0
  • 1 comments

📋 MPM BioVentures 2014, L.P. (Shareholder) plans to sell 89K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $90K) Filed: Dec 10, 2025 | ID: 056348

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Dec. 10, 2025, 22:01 UTC
  • 0
  • 1 comments

📋 MPM BioVentures 2014 (B), L.P. (Shareholder) plans to sell 6K shares of Werewolf Therapeutics, Inc. (at $1.01 each, total $6K) Filed: Dec 10, 2025 | ID: 056347

Comment Full text

STAAR Surgical Company (STAA)

  • SEC News
  • Dec. 10, 2025, 22:00 UTC
  • 0
  • 0 comments

New Form DFAN14A - STAAR SURGICAL CO Filed: 2025-12-10 AccNo: 0001213900-25-120140 Size: 2 MB

Comment Full text

Onconetix, Inc. (ONCO)

  • SEC News
  • Dec. 10, 2025, 22:00 UTC
  • 0
  • 1 comments

(99% Neutral) Onconetix, Inc. (ONCO) Announces Executive Changes

Comment Full text

Catalyst Pharmaceuticals Inc. (CPRX)

  • SEC News
  • Dec. 10, 2025, 22:00 UTC
  • 0
  • 1 comments

Elsbernd Brian 🟡 adjusted position in 2.8K shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) Transaction Date: Dec 08, 2025 | Filing ID: 000445

Comment Full text

Catalyst Pharmaceuticals Inc. (CPRX)

  • SEC News
  • Dec. 10, 2025, 22:00 UTC
  • 0
  • 1 comments

Miller Steve 🟡 adjusted position in 0 shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) Transaction Date: Dec 08, 2025 | Filing ID: 000448

Comment Full text

Catalyst Pharmaceuticals Inc. (CPRX)

  • SEC News
  • Dec. 10, 2025, 22:00 UTC
  • 0
  • 1 comments

Director Tierney David S 🟡 adjusted position in 0 shares (1 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) Transaction Date: Dec 08, 2025 | Filing ID: 000451

Comment Full text
  • Previous
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Search

News categories

  • Technical Exchange News(10541)
  • Event(1887)
  • SEC News(182770)
  • FDA Approval(9780)
  • Company Report(721)
  • Business News(121279)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin